REG - Hutchison China Medi - Holding(s) in Company
RNS Number : 2351SHutchison China Meditech Limited07 July 2020TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft
Word format if possible)i
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:
Hutchison China MediTech Limited
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer
X
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights
X
An acquisition or disposal of financial instruments
X
An event changing the breakdown of voting rights
Other (please specify)iii:
3. Details of person subject to the notification obligationiv
Name
General Atlantic Singapore HCM Pte. Ltd.
City and country of registered office (if applicable)
Singapore
4. Full name of shareholder(s) (if different from 3.)v
Name
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reachedvi:
06/07/2020
6. Date on which issuer notified (DD/MM/YYYY):
06/07/2020
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8. A)
% of voting rights through financial in- struments
(total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)
Total number of voting rights of issuervii
Resulting situation on the date on which
threshold was crossed or reached
2.81%
2.35%
5.16%
710,574,765
Position of previous notification (if applicable)
8. Notified details of the resulting situation on the date on which the threshold was crossed or
reachedviii
A: Voting rights attached to shares
Class/type of shares
ISIN code (if possible)
Number of voting rightsix
% of voting rights
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
Ordinary Shares KYG4672N1198
20,000,000
2.81%
SUBTOTAL 8. A
20,000,000
2.81%
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument
Expiration datex
Exercise/ Conversion Periodxi
Number of voting rights that may be acquired if the instrument is
exercised/converted.
% of voting rights
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument
Expiration datex
Exercise/ Conversion Period xi
Physical or cash settlementxii
Number of voting rights
% of voting rights
Warrants over
Ordinary Shares
January 3,
2022
At any time after July 2,
2020
Physical
16,666,670
2.35%
SUBTOTAL 8.B.2
16,666,670
2.35%
9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii
Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)
X
Namexv
% of voting rights if it equals or is higher than the notifiable threshold
% of voting rights through financial in- struments if it equals or is higher than the
notifiable threshold
Total of both if it equals or is higher than the notifiable threshold
GAP (Bermuda) Limited
5.16%
General Atlantic LLC
5.16%
General Atlantic GenPar (Bermuda), L.P.
5.16%
General Atlantic (Lux) S.à r.l.
5.16%
General Atlantic GenPar (Lux) SCSp, L.P.
5.16%
General Atlantic Part- ners (Bermuda) IV, L.P.
5.16%
General Atlantic Part- ners (Bermuda) EU, L.P.
5.16%
General Atlantic Part- ners (Lux) SCSp, L.P.
5.16%
GAP Coinvestments III, LLC
5.16%
GAP Coinvestments IV, LLC
5.16%
GAP Coinvestments V, LLC
5.16%
GAP Coinvestments CDA, L.P.
5.16%
General Atlantic Singa- pore Interholdco Ltd.
5.16%
General Atlantic Singa- pore Fund Pte. Ltd.
5.16%
General Atlantic Singa- pore HCM Pte. Ltd.
5.16%
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional informationxvi
The warrants in Box B 2 have not been exercised, in part or whole, as of the below "Date of completion." Accordingly, the "Total number of voting rights of issuer" in Box 7 do not account for any issuance of the new voting shares, in part or whole, from the exercise of the warrants.
Once the warrants are exercised in full, assuming no other changes in the interests or the voting shares in the meantime, the "Total number of voting rights of issuer" in Box 7 will become 727,241,435. On that
basis, the ownership ordinary shares would represent 2.75%, the ownership of warrants would represent 2.29%, and the combined ownership of the ordinary shares and warrants would represent 5.04%.
Place of completion
Hong Kong, China
Date of completion
July 6, 2020
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDHOLUBSNRRKUBRRR
Recent news on HUTCHMED (China)
See all newsREG - Hutchmed China Ltd - Japan Approval for FRUZAQLA
AnnouncementRCS - Hutchmed China Ltd - Clinical Data to be Presented at ESMO and WCLC
AnnouncementREG - Hutchmed China Ltd - Total Voting Rights
AnnouncementREG - Hutchmed China Ltd - Update on Fruquintinib for Gastric Cancer in China
AnnouncementREG - Hutchmed China Ltd - Standard form for notification of major holdings
Announcement